CYP2C19 Metabolizer Status Does Not Influence the Safety or Efficacy of Pentamidine
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.596
Abstract: Background Pneumocystis jirovecii (PJP) infections are a significant cause of morbidity and mortality in recipients of hematopoietic cell transplantations (HCT), and PJP prophylaxis is a standard of care. The gold standard for PJP prophylaxis is… read more here.
Keywords: metabolizer status; cyp2c19 metabolizer; metabolizer; function ... See more keywords
CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1016126
Abstract: Background Dyslipidemia is a major cause of arteriosclerotic cardiovascular disease (ASCVD), and low-density lipoprotein cholesterol (LDL-C) is the profile to be reduced to prevent disease progression. Small dense low-density lipoprotein cholesterol (sdLDL-C) has been proven… read more here.
Keywords: cyp2c19 metabolizer; efficacy statins; metabolizer; metabolizer phenotypes ... See more keywords